Gazyva Infusion Could Be Shorter for Some NHL Patients, Study Finds
News
Shortening the time needed for an infusion of Gazyva (obinutuzumab) did not affect the safety of Japanese patients with previously untreated CD20-positive B-cell non-Hodgkin’s lymphoma, a new study shows. “Safety, tolerability ... Read more